| Erika Mcmahon, MD | |
|
1105 Sixth St, Traverse City, MI 49684-2345 | |
| (231) 947-0673 | |
| (801) 740-2847 |
| Full Name | Erika Mcmahon |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 10 Years |
| Location | 1105 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437567252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 59488 (Minnesota) | Secondary |
| 207P00000X | Emergency Medicine | 4301113292 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Michigan Emergency Physicians Pc | 7214933928 | 35 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
| Entity Name | Kalkaska Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013183060 PECOS PAC ID: 3577536002 Enrollment ID: O20040813000668 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
| Entity Name | Northwestern Michigan Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073597944 PECOS PAC ID: 7214933928 Enrollment ID: O20061019000359 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
| Entity Name | Dlp Marquette Physician Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487902995 PECOS PAC ID: 9931359601 Enrollment ID: O20121016000312 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erika Mcmahon, MD Northwestern Michigan Emergency Physicians, P.c., 4624 N Spider Lake Road, Traverse City, MI 49696 Ph: (231) 947-0673 | Erika Mcmahon, MD 1105 Sixth St, Traverse City, MI 49684-2345 Ph: (231) 947-0673 |
News Archive
A new study suggests that changes in gastric physiology perform better than standard polygraph methods in distinguishing between lying and telling the truth.
Some people are oblivious to the odor in the locker room after a game, while others wrinkle their noses at the slightest whiff of sweat.
Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell on June 15, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one NSAID, called Sulindac, inhibits tumor growth.
› Verified 2 days ago
Bevin Clayton, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Dale C Blum, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Dr. Brandi Jenks Gunn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Richard G Faller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
David Darwin Nicolaou, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-8710 | |
David Shapiro, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 Sixth St, Traverse City, MI 49684 Phone: 231-395-6333 Fax: 801-740-2847 | |
Juhn Mark Han, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 |